MX2022006984A - Procesos e intermediario para la preparacion de oxetan-2-ilmetanamina. - Google Patents
Procesos e intermediario para la preparacion de oxetan-2-ilmetanamina.Info
- Publication number
- MX2022006984A MX2022006984A MX2022006984A MX2022006984A MX2022006984A MX 2022006984 A MX2022006984 A MX 2022006984A MX 2022006984 A MX2022006984 A MX 2022006984A MX 2022006984 A MX2022006984 A MX 2022006984A MX 2022006984 A MX2022006984 A MX 2022006984A
- Authority
- MX
- Mexico
- Prior art keywords
- preparation
- ylmethanamine
- oxetan
- salt
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/02—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D305/04—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D305/06—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epoxy Compounds (AREA)
Abstract
Un proceso e intermediario para la preparación de un compuesto de fórmula I: (ver Fórmula) o una sal del mismo.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962946146P | 2019-12-10 | 2019-12-10 | |
| PCT/US2020/063546 WO2021118906A1 (en) | 2019-12-10 | 2020-12-07 | Process and intermediate for the preparation of oxetan-2-ylmethanamine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2022006984A true MX2022006984A (es) | 2022-07-13 |
Family
ID=74003942
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2022006984A MX2022006984A (es) | 2019-12-10 | 2020-12-07 | Procesos e intermediario para la preparacion de oxetan-2-ilmetanamina. |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US20230013840A1 (es) |
| EP (1) | EP4073051B1 (es) |
| JP (1) | JP7292517B2 (es) |
| KR (1) | KR102635237B1 (es) |
| CN (1) | CN114728923A (es) |
| AU (1) | AU2020401539B2 (es) |
| BR (1) | BR112022008892A2 (es) |
| CA (1) | CA3160419A1 (es) |
| CL (1) | CL2022001511A1 (es) |
| CO (1) | CO2022008127A2 (es) |
| DK (1) | DK4073051T3 (es) |
| EC (1) | ECSP22046595A (es) |
| ES (1) | ES2975599T3 (es) |
| FI (1) | FI4073051T3 (es) |
| HR (1) | HRP20240343T1 (es) |
| IL (1) | IL292707A (es) |
| LT (1) | LT4073051T (es) |
| MA (1) | MA58104B1 (es) |
| MD (1) | MD4073051T2 (es) |
| MX (1) | MX2022006984A (es) |
| PE (1) | PE20230183A1 (es) |
| PL (1) | PL4073051T3 (es) |
| PT (1) | PT4073051T (es) |
| RS (1) | RS65238B1 (es) |
| SI (1) | SI4073051T1 (es) |
| UA (1) | UA127884C2 (es) |
| WO (1) | WO2021118906A1 (es) |
| ZA (1) | ZA202205170B (es) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7208140B2 (en) * | 2003-02-19 | 2007-04-24 | Schering Aktiengesellschaft | Trimeric macrocyclic substituted benzene derivatives |
| WO2012153155A1 (en) | 2011-05-06 | 2012-11-15 | Egis Gyógyszergyár Nyilvãnosan Müködö Részvény-Társaság | Process for the preparation of a rivaroxaban and intermediates formed in said process |
| EP2847177B1 (en) | 2012-05-09 | 2017-10-11 | Boehringer Ingelheim International GmbH | Methods for making oxetan-3-ylmethanamines |
| PL3555064T3 (pl) * | 2016-12-16 | 2023-03-06 | Pfizer Inc. | Agoności receptora GLP-1 i ich zastosowania |
| CN109265389B (zh) * | 2018-08-31 | 2020-08-18 | 南京富润凯德生物医药有限公司 | 2-(氨基甲基)-1-氧杂-7-氮杂螺[3.5]壬烷衍生物、中间体及其制备方法 |
-
2020
- 2020-12-07 IL IL292707A patent/IL292707A/en unknown
- 2020-12-07 DK DK20829133.6T patent/DK4073051T3/da active
- 2020-12-07 KR KR1020227018626A patent/KR102635237B1/ko active IP Right Grant
- 2020-12-07 MX MX2022006984A patent/MX2022006984A/es unknown
- 2020-12-07 SI SI202030381T patent/SI4073051T1/sl unknown
- 2020-12-07 FI FIEP20829133.6T patent/FI4073051T3/fi active
- 2020-12-07 MD MDE20221148T patent/MD4073051T2/ro unknown
- 2020-12-07 US US17/779,447 patent/US20230013840A1/en active Pending
- 2020-12-07 JP JP2022534655A patent/JP7292517B2/ja active Active
- 2020-12-07 CA CA3160419A patent/CA3160419A1/en active Pending
- 2020-12-07 PT PT208291336T patent/PT4073051T/pt unknown
- 2020-12-07 ES ES20829133T patent/ES2975599T3/es active Active
- 2020-12-07 MA MA58104A patent/MA58104B1/fr unknown
- 2020-12-07 WO PCT/US2020/063546 patent/WO2021118906A1/en active Application Filing
- 2020-12-07 AU AU2020401539A patent/AU2020401539B2/en active Active
- 2020-12-07 HR HRP20240343TT patent/HRP20240343T1/hr unknown
- 2020-12-07 BR BR112022008892A patent/BR112022008892A2/pt active IP Right Grant
- 2020-12-07 EP EP20829133.6A patent/EP4073051B1/en active Active
- 2020-12-07 PE PE2022001046A patent/PE20230183A1/es unknown
- 2020-12-07 CN CN202080082957.9A patent/CN114728923A/zh active Pending
- 2020-12-07 LT LTEPPCT/US2020/063546T patent/LT4073051T/lt unknown
- 2020-12-07 UA UAA202201389A patent/UA127884C2/uk unknown
- 2020-12-07 RS RS20240243A patent/RS65238B1/sr unknown
- 2020-12-07 PL PL20829133.6T patent/PL4073051T3/pl unknown
-
2022
- 2022-05-10 ZA ZA2022/05170A patent/ZA202205170B/en unknown
- 2022-06-08 CL CL2022001511A patent/CL2022001511A1/es unknown
- 2022-06-08 CO CONC2022/0008127A patent/CO2022008127A2/es unknown
- 2022-06-10 EC ECSENADI202246595A patent/ECSP22046595A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA202205170B (en) | 2024-09-25 |
| SI4073051T1 (sl) | 2024-04-30 |
| DK4073051T3 (da) | 2024-02-26 |
| FI4073051T3 (fi) | 2024-03-28 |
| MA58104B1 (fr) | 2024-05-31 |
| WO2021118906A1 (en) | 2021-06-17 |
| EP4073051A1 (en) | 2022-10-19 |
| HRP20240343T1 (hr) | 2024-05-24 |
| JP7292517B2 (ja) | 2023-06-16 |
| US20230013840A1 (en) | 2023-01-19 |
| IL292707A (en) | 2022-07-01 |
| ECSP22046595A (es) | 2022-07-29 |
| AU2020401539B2 (en) | 2023-06-01 |
| PE20230183A1 (es) | 2023-02-01 |
| MD4073051T2 (ro) | 2024-08-31 |
| CL2022001511A1 (es) | 2023-01-20 |
| LT4073051T (lt) | 2024-03-12 |
| UA127884C2 (uk) | 2024-01-31 |
| BR112022008892A2 (pt) | 2022-08-23 |
| RS65238B1 (sr) | 2024-03-29 |
| KR102635237B1 (ko) | 2024-02-13 |
| PT4073051T (pt) | 2024-02-21 |
| EP4073051B1 (en) | 2024-02-07 |
| CN114728923A (zh) | 2022-07-08 |
| JP2023504581A (ja) | 2023-02-03 |
| ES2975599T3 (es) | 2024-07-09 |
| CA3160419A1 (en) | 2021-06-17 |
| CO2022008127A2 (es) | 2022-06-10 |
| KR20220097941A (ko) | 2022-07-08 |
| AU2020401539A1 (en) | 2022-06-16 |
| PL4073051T3 (pl) | 2024-05-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12020500673A1 (en) | Compounds | |
| CL2022001731A1 (es) | Inhibidores de egfr. | |
| CR20220251A (es) | Nuevos derivados de metilquinazolinona | |
| MX2022014864A (es) | Compuestos de bisamida que activan el sarcomero y sus usos. | |
| SA519402288B1 (ar) | مركب بيريميدين واستخداماته الصيدلانية | |
| ZA202201503B (en) | Urea compound for antagonizing lpa1 receptor | |
| MX2022002831A (es) | Compuestos heterociclicos. | |
| MX2023014281A (es) | Lipidos novedosos. | |
| PH12020500341A1 (en) | Pentacyclic compound | |
| ZA202101487B (en) | Novel compounds | |
| MY193239A (en) | Novel b-lactamase inhibitors | |
| MX2019001228A (es) | Metodo de produccion del compuesto de pirazol-amida. | |
| JOP20200256A1 (ar) | طريقة لتحضير 1، 2، 4-تريازولون يحمل ثلاثة بدائل في المواقع 2، 4، 5 | |
| PH12019500370A1 (en) | Triazolopyrazinone derivative useful as a human pde1 inhibitor | |
| PH12018500999A1 (en) | Sodium channel blocker | |
| MX2022002017A (es) | Metodo para producir derivado de heterociclideno acetamida. | |
| MX2021009261A (es) | Compuesto de fluorovinilbenzamida como inmunomodulador pd-l1. | |
| WO2020139971A3 (en) | Methods for making dimeric naphthalimides and solid state forms of the same | |
| EP4289844A3 (en) | A process for making palbociclib | |
| ZA202205170B (en) | Process and intermediate for the preparation of oxetan-2-ylmethanamine | |
| WO2019048923A3 (en) | Trans-isomeric heterocyclic compounds and preparation thereof | |
| AU2019248350A8 (en) | Process for making sarecycline hydrochloride | |
| SA522431572B1 (ar) | مركب بيريميدين-5-كربوكساميد | |
| SA119400353B1 (ar) | مشتق بيرازول مستبدل | |
| WO2018055528A3 (en) | Processes for the preparation of eluxadoline |